NUTEX HEALTH INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$200.15
-4.74%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-5.7%
3 months
+30.9%
6 months
+43.4%
1 year
+60.8%
Year to date
+21.6%
52-week range
$87.01 – $225.00
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$1.37B
P/E
7.6
P/B
3.5
P/S
1.6
Revenue
$846.72M
Net income
$179.92M
Diluted EPS
25.27
Gross margin
51.30%
Net margin
21.20%
Return on equity
51.90%
Total debt
$347.34M
Cash
$207.11M
Free cash flow
$274.17M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $210.75M | $65.84M | 67.00% | 31.20% | $31.66M |
| Mar 31, 2026 | $216.49M | $46.81M | 42.40% | 21.60% | $74.32M |
| Dec 31, 2025 | $151.68M | $11.83M | 30.40% | 7.80% | $68.98M |
| Sep 30, 2025 | $267.8M | $55.44M | 57.80% | 20.70% | $99.21M |
| Jun 30, 2025 | $243.99M | -$17.7M | 51.20% | -7.30% | $26.51M |
| Mar 31, 2025 | $211.79M | $14.63M | 55.90% | 6.90% | $50.9M |
| Dec 31, 2024 | $257.62M | $61.7M | 55.00% | 23.90% | -$341.78K |
| Sep 30, 2024 | $78.79M | -$8.79M | 27.80% | -11.20% | $6.17M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent NUTX news
All market newsNo ticker-linked stories are in the current archive.